'Wrong gender, color, country' - India-born Aiyengar, JPMorgan's rising star

February 5, 2014

JP_Morgans_chase

Washington, Feb 5: Fifteen years ago, when Anu Aiyengar went for an interview to become a mergers and acquisitions banker at a major Wall Street firm, she got a stark, disappointing message.

"You have three strikes against you," Aiyengar, who was born in India, recalled the interviewer telling her. "How can I hire you? You are the wrong gender, wrong color and wrong country."

Aiyengar, now a managing director at JPMorgan Chase & Co (JPM.N), is seen as one of the rising stars within the largest U.S. bank's M&A group, advising clients in sectors ranging from retail to industrials.

Over the past 15 years at JPMorgan, she has worked on around $200 billion worth of transactions. Last year, she advised on such deals as auto parts retailer Advance Auto Parts Inc's $2 billion purchase of General Parts International Inc, and office supply company Office Depot Inc's $1 billion acquisition of rival OfficeMax Inc. JPMorgan was ranked No. 2 in M&A deals by value globally last year.

Being a woman, she said, has proven to be an advantage in connecting with clients, so much so that many become friends or mentors. "Maybe it's stereotypical, but I do feel that listening skills are pretty important," she said.

Former OfficeMax CEO Ravi Saligram said Aiyengar gained his trust with her analytical skills and because she spoke her mind.

"She's not afraid to push back," Saligram said. "She was not a ‘yes' person."

Still, Aiyengar said she rarely comes across other women in her business, a reflection of how corporate America and Wall Street remain male-dominated, even if the kind of overt prejudice that she experienced fifteen years ago has receded.

Women made up 15.6 percent of top executives and managers at U.S. investment banks in 2012, compared with 17.7 percent in 2007, according to annual studies published by the United States Equal Employment Opportunity Commission (EEOC).

Elizabeth Nesvold, a managing director at the women-owned M&A advisory firm Silver Lane Advisors, has a similar story to tell. Nesvold, who has been a banker for more than two decades, said it took 16 years until she sat across from another female senior banker during deal negotiations.

Nesvold said she also thinks being a woman helps at times.

"Sometimes clients have told me things that I am 100 percent sure they would have not told a man," Nesvold said. "The work-life balance is challenging, while we see a lot of young women come into the profession, we do not see that many senior women stay the course."

Aiyengar said she makes an effort to find that balance. Married for 18 years with no children, Aiyengar, who remains an Indian citizen, said she finds relaxation through Indian classical dance and tries to stay in touch with friends and family outside of banking. She also tries to mentor younger women bankers.

"I am very passionate about having more women in broader financial services, and especially banking, not just M&A," she said.

Aiyengar herself benefited from mentors such as Eric Stein, JPMorgan's head of investment banking coverage for North America, who helped her with everything from learning how to building deal models to the intricacies of American football.

"He spent six hours on a white board teaching me how to set up a model," she said. "My basic checking models are still set up the way he originally taught me."

Stein said it is rare to find a banker who can handle a wide range of deals, from financial services to retail. Teaching her American football, however, was another matter.

"There is no doubt teaching her football was more difficult, but part of the reason was I tried to convince her to join me in being a Buffalo Bills fan," Stein said. "I am proud to say she is getting there after close to 20 years, and much more quickly than I have picked up on cricket."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 21,2020

Washington D.C., April 21: North Korea's leader, Kim Jong Un, is in grave danger following a surgery this month, according to a US intelligence official with direct knowledge.

Kim recently missed the celebration of his grandfather's birthday on April 15, which raised speculation about his well-being. He had been seen four days before that at a government meeting, according to intelligence reports cited by CNN.

The National Security Council and Office of the Director of National Intelligence have however declined to comment on the matter.

CNN has also reached out to the CIA and the State Department for comment and sought comment from the South Koreans.

Kim's absences from official state media often spark speculation and rumors about his health. North Korea has no free press and is often a black hole when it comes to the country's leadership. Analysts are heavily reliant on scanning state media dispatches and watching propaganda videos for any semblance of a clue.

Kim last appeared in North Korean state media on April 11. April 15 -- North Korea's most important holiday, the anniversary of the birth of the country's founding father, Kim Il Sung -- came and went without any official mention of Kim Jong Un's movements.

Experts are unsure of what to make of Kim's absence from any festivities celebrating his grandfather. When North Korean leaders have not shown up to these important celebrations in the past, it has portended major developments. But it has also turned out to be nothing.

"There have been a number of recent rumours about Kim's health (smoking, heart, and brain). If Kim is hospitalized, it would explain why he wasn't present on the important April 15th celebrations," said Bruce Klingner, a senior research fellow at the Heritage Foundation and former CIA deputy division chief for North Korea. "But, over the years, there have been a number of false health rumors about Kim Jong-un or his father. We'll have to wait and see."

Kim Jong Il's absence from a parade celebrating North Korea's 60th anniversary in 2008 was followed by rumblings that he was in poor health. It was later revealed he had a stroke, after which his health continued to decline until his death in 2011.

Kim Jong Un disappeared from the public eye for more than a month in 2014, which also prompted speculation about his health. He returned sporting a cane, and days later South Korean intelligence said that he had a cyst removed from his ankle.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 3,2020

Islamabad, Jul 3: The US embassy here in a statement on Friday said the Trump administration through the US Agency for International Development (USAID) “donated a shipment of 100 brand-new, state-of-the-art ventilators” to Pakistan.

The ventilators arrived in Karachi on July 2 and will be sent to hospitals across Pakistan.

“This donation delivers on President Donald Trump’s generous offer of these critically-needed supplies and supports Pakistan’s urgent response to the pandemic,” the embassy said.

Made in America, the ventilators are valued at about $3 million and reflect the latest in cutting-edge medical design and technology, it said.

They are compact, easily deployable, and will enable Pakistan to more effectively treat patients suffering from Covid-19.

The US-Pakistan health partnership to curb the spread of the novel coronavirus is helping to improve and expand laboratory testing, disease monitoring, case tracking, infection prevention and control and patient care, the embassy said.

The US has contributed nearly $27 million in new funding so far to this vital partnership that is growing every day. "We are also thankful for Pakistan's contribution of medical supplies to help fight coronavirus in the US," the embassy said in the statement.

Ambassador Paul Jones said, “The US stands with Pakistan in its fight against the coronavirus. These American-made ventilators will help Pakistani patients in the most acute need of medical care."

The announcement comes days after Pakistan said it had started producing locally designed ventilators.

Pakistan reported 78 more deaths from the coronavirus in the past 24 hours, raising virus-related fatalities to 4,551 while the total number of confirmed cases has increased to 221,896.

On Friday, the health authorities said 1,13,623 persons have recovered from the coronavirus, surpassing the number of active Covid-19 infections in the country for the first time.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.